Product: | Memantine-d6 HCl | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catalog Number: | D27788 | ||||||||||||
Synonyms: |
3,5-(Dimethyl-d6)tricyclo[3.3.1.13,7]decan-1-amine HCl; 3,5-(Dimethyl-d6)-1-adamantanamine; 1-Amino-3,5-(dimethyl-d6)adamantane HCl; Akatinol-d6; Axura-d6; Ebix-d6; Ebixia-d6; Ebixza-d6; NSC 102290-d6; Namenda-d6; SUN Y7017-d6 |
||||||||||||
Pricing: |
|
||||||||||||
Formula: | C12H16D6ClN | ||||||||||||
Enrichment: | 99% D | ||||||||||||
Chemical Purity: | 98% | ||||||||||||
Molecular Weight: | 221.89 | ||||||||||||
Structure: | |||||||||||||
Category: | Chemical Amines | ||||||||||||
Literature References: |
Reisberg, B; Doody, R; Stöffler, A; Schmitt, F; Ferris, S; Möbius, HJ, Memantine in moderater-to-severe Alzheimer's disease. New Engl. J. Med., 2003, 348 (14): 1333–41.; Aarsland, D; Ballard, C; Walker, Z; Bostrom, F; Alves, G; Kossakowski, K; Leroi, I; Pozo-Rodriguez, F; Minthon, L; Londos, E ., Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet neurology, 2009, July; 8 (7): 613–8. |
||||||||||||
MSDS: | |||||||||||||
Applications: | A labeled novel class Alzheimer's disease medication. Acts on the glutamatergic system by blocking NMDA receptors. Shows modest effect in moderate-to-severe Alzheimer's disease and dementia with Lewy bodies. |